Skip to main content
. 2015 May 27;6(21):18613–18630. doi: 10.18632/oncotarget.4317

Table 2. Sequences of miRNAs or shRNAs used in the study.

Name Sequences
miR-451 inhibitor 5′-AACUCAGUAAUGGUAACGGUUU-3′
miR-451 mimics F 5′-AAACCGUUACCAUUACUGAGUU-3′
R 5′-CUCAGUAAUGGUAACGGUUUUU-3′
sh-control F 5′-CCGGGCTTCTCCGAACGTGTCACGTCTCGAGAAGAAACCAGTAAACGTAAGCTTTTTG-3′
R 5′-AATTCAAAAAGCTTCTCCGAACGTGTCACGTCTCGAGAAGAAACCAGTAAACGTAAGC-3′
sh-c-myc #1 F 5′-CCGGCCCAAGGTAGTTATCCTTAAACTCGAGTTTAAGGATAACTACCTTGggTTTTTG-3′
R5′-AATTCAAAAACCCAAGGTAGTTATCCTTAAACTCGAGTTTAAGGATAACTACCTTGGG-3′
sh-c-myc #2 F 5′-CCGGCAGTTGAAACACAAACTTGAACTCGAGTTCAAGTTTGTGTTTCAACtgTTTTTG-3′
R 5′-AATTCAAAAACAGTTGAAACACAAACTTGAACTCGAGTTCAAGTTTGTGTTTCAACTG-3′
sh-c-myc #3 F 5′-CCGGCAGGAACTATGACCTCGACTACTCGAGTAGTCGAGGTCATAGTTCCtgTTTTTG-3′
R 5′-AATTCAAAAACAGGAACTATGACCTCGACTACTCGAGTAGTCGAGGTCATAGTTCCTG-3′